Compare ETHZ & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ETHZ | ARCT |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 221.9M | 194.1M |
| IPO Year | N/A | N/A |
| Metric | ETHZ | ARCT |
|---|---|---|
| Price | $10.51 | $7.13 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $38.67 |
| AVG Volume (30 Days) | 881.1K | ★ 943.4K |
| Earning Date | 01-26-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $4,110,169.00 | ★ $97,601,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.58 | $5.85 |
| 52 Week High | $174.60 | $24.17 |
| Indicator | ETHZ | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 44.05 | 37.15 |
| Support Level | $9.33 | $6.07 |
| Resistance Level | $11.82 | $6.90 |
| Average True Range (ATR) | 1.04 | 0.42 |
| MACD | -0.34 | 0.41 |
| Stochastic Oscillator | 22.79 | 80.27 |
ETHZilla Corporation is a technology company in the decentralized finance industry. It seeks to connect financial institutions, businesses and organizations worldwide by enabling secure, accessible blockchain transactions through Ethereum Network protocol implementations. It generates recurring revenues through various DeFi protocols that improve Ethereum network integrity and security. The group enables the seamless tokenization of traditional assets by bringing them on-chain. Leveraging its proprietary protocol solutions, ETHZilla supports DeFi transactions, asset digitization across various Layer 2 Ethereum networks. The platform is focused on delivering tokenization services, DeFi protocol integrations, blockchain analytics, gateways for converting traditional assets to digital forms.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.